Sponsor or institution

Clinical trials and research at Zhejiang Cancer Hospital

• 67Clinical trials
• 2New in 30 days
• 1Country

Newest trials

All recruiting trials (67)

• Me capegfilgrastim to help prevent neutropenia in advanced breast cancer patients on chemotherapy

  This real-world registry tests whether mecapegfilgrastim used with chemotherapy helps prevent low white blood cells in adults with advanced breast cancer.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07899099

• Pucotenlimab and Anlotinib with Chemo Before Surgery for Early-Stage Triple-Negative Breast Cancer

  This study tests a combo of pucotenlimab, anlotinib, and nab-paclitaxel before surgery in adults with newly diagnosed, stage II-III triple-negative breast cancer that is PD-L1 known.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou · NCT07896668

• Anti-PD-1 with chemotherapy and intraperitoneal nab-paclitaxel for untreated advanced gastric cancer with ascites

  This study tests whether adding anti-PD-1 therapy to standard chemotherapy plus intraperitoneal nab-paclitaxel can help patients with untreated advanced gastric cancer and malignant ascites.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07855640

• Carbon ion lattice radiotherapy for large thoracic tumors

  This study tests a carbon ion lattice radiotherapy approach, after induction chemoimmunotherapy, in adults with unresectable locally advanced NSCLC or other thoracic solid tumors.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07744074

• Immunotherapy Plus Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer

  This trial tests whether adding immunotherapy and chemotherapy to carbon ion radiotherapy can help women with locally advanced cervical cancer live longer without the cancer growing.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07702838

• Olaparib with Trastuzumab and Pertuzumab before surgery for older women with HER2-positive breast cancer

  This trial tests whether adding olaparib to standard HER2-targeted therapy can help older women with newly diagnosed, operable HER2-positive breast cancer before surgery.

  Recruiting Phase 4 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07695259

• IBI343 with chemotherapy in advanced pancreatic cancer

  This study tests whether IBI343 combined with chemotherapy is safe and can help people with advanced pancreatic cancer.

  Recruiting Phase 1/2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07692750

• 68Ga-EV203: How the tracer spreads in the body and its safety in blood cancers

  This study tests how 68Ga-EV203 distributes in the body, the radiation dose it delivers, and its safety in adults with multiple myeloma, non-Hodgkin lymphoma, or AML.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07670949

• Metronomic Oral Paclitaxel for Advanced HER2-Negative Breast Cancer

  This study tests whether low, regular doses of an oral paclitaxel solution can be safely used to control tumor growth in adults with advanced HER2-negative breast cancer who have already had prior cancer therapy.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07602907

• Ultra-low-dose radiation followed by orelabrutinib for early-stage MALT lymphoma

  This study will test whether a short course of very low-dose radiation followed by daily orelabrutinib helps adults with stage I–II MALT lymphoma keep their disease controlled with acceptable side effects.

  Recruiting at 2 sites Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang and 1 other locations · NCT07554898

• Injectable NC527-X to improve intraoperative imaging during solid tumor surgery

  We will test a preoperative injection of NC527-X to help surgeons see solid tumors more clearly during surgery in adults.

  Recruiting Phase 1 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07538648

• CAR-T plus autologous stem-cell transplant for relapsed or high-risk large B‑cell lymphoma

  This trial will try CAR-T cell therapy together with an autologous stem-cell transplant in adults whose large B‑cell lymphoma has relapsed or is refractory and who have high‑risk features.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhengjiang · NCT07538635

• Switching between two HER2-targeted regimens (HP+chemotherapy vs HPy+chemotherapy) after progression in advanced HER2-positive breast cancer

  This project tests whether switching between two HER2-targeted regimens (HP+chemo and HPy+chemo) after progression helps people with HER2-positive advanced or metastatic breast cancer.

  Recruiting Zhejiang Cancer Hospital · Zhejiang, Hangzhou · NCT07455188

• Umbilical cord blood therapy for cancer treatment–related low platelets

  This trial will try an intravenous umbilical cord blood infusion to see if it raises platelet counts in people aged 12–65 with cancer treatment–induced thrombocytopenia.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07441720

• Thiotepa with pirtobrutinib and sintilimab for frail or relapsed/refractory CNS lymphoma

  This treatment combines thiotepa with pirtobrutinib and sintilimab for adults who are frail or whose primary or secondary central nervous system lymphoma has relapsed or not responded to prior therapy.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07416890

• Entinostat with or without anlotinib plus fulvestrant for HR-positive, HER2-negative advanced breast cancer after endocrine therapy

  This trial tests whether adding entinostat, with or without anlotinib, to fulvestrant helps women with HR+/HER2- advanced breast cancer whose disease progressed after endocrine therapy and CDK4/6 inhibitors.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Zhejiang, Hangzhou · NCT07330544

• Perioperative IBI363 plus chemotherapy for MHC-II–negative locally advanced gastric and gastroesophageal junction adenocarcinoma

  Tests whether adding the experimental drug IBI363 to standard perioperative chemotherapy helps adults (18–75) with MHC‑II–negative locally advanced gastric or gastroesophageal junction adenocarcinoma.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07325630

• Disitamab vedotin (RC48) plus carboplatin as first-line treatment for advanced HER2-positive ovarian, fallopian tube, or primary peritoneal cancer

  This trial will test whether combining disitamab vedotin (RC48) with carboplatin works and is safe as a first-line treatment for people with advanced HER2-positive ovarian, fallopian tube, or primary peritoneal cancer who have had initial debulking surgery.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Zhejiang, Zhejiang · NCT07285941

• Hepatic arterial infusion of albumin‑bound paclitaxel plus nedaplatin for breast cancer liver metastases

  This treatment will try giving albumin‑bound paclitaxel plus nedaplatin directly into the liver artery for people whose breast cancer has spread only to the liver after standard treatments have failed.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07284836

• Real-time imaging of normal throat and larynx motion during a barium swallow

  This project will record routine barium-swallow X-rays to see how normal throat and voice-box structures move in adults.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07264322

• Electroacupuncture for Postoperative Urinary Retention After Cervical Cancer Surgery

  This trial tests whether electroacupuncture can help people with POUR after radical hysterectomy for cervical cancer, compared with a sham treatment.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07253194

• American ginseng's effects on urine and blood metabolites

  This test will see if taking 3 grams of American ginseng daily for 14 days changes metabolites in urine and blood in healthy adults.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07252362

• First-line sequential AG and mFOLFOX with serplulimab and bevacizumab versus AG alone for advanced pancreatic cancer

  This trial will test whether adding serplulimab and bevacizumab to sequential AG and mFOLFOX chemotherapy helps people with untreated advanced pancreatic cancer live longer than standard AG chemotherapy alone.

  Recruiting Phase 3 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07235930

• Transcutaneous electrical acupoint stimulation for postoperative urinary retention after radical hysterectomy for cervical cancer

  We will try transcutaneous electrical acupoint stimulation (TEAS) versus a sham TEAS to help people who cannot fully empty their bladder after radical hysterectomy for cervical cancer.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07235371

• CT imaging comparison of GMA-Tulip, I-gel, and LMA Supreme laryngeal masks

  This project will use CT scans to see if three laryngeal masks (GMA-Tulip, I-gel, and LMA Supreme) sit differently and compress surrounding tissues in adults having CT-guided procedures under general anesthesia.

  Recruiting at 2 sites Zhejiang Cancer Hospital · Hangzhou, Zhejiang and 1 other locations · NCT07196696

• Short-course radiotherapy followed by AK112 in mid-low rectal cancer with pMMR/MSS

  This trial tests whether a short course of pelvic radiotherapy plus the IV drug ivonesimab (AK112) can produce a complete response in adults with a certain type of rectal cancer.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07162714

• GRAPE model for gastric cancer screening

  This project will test whether the GRAPE computer model can help detect gastric cancer in adults aged 18–80 who are having thoracoabdominal CT scans.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07067983

• Pyrotinib + Dalpiciclib + Letrozole for ER-positive, HER2-positive advanced breast cancer

  This trial tests whether combining pyrotinib, dalpiciclib, and letrozole can help people with ER-positive, HER2-positive advanced breast cancer.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07014410

• Treatment for metastatic nasopharyngeal carcinoma using a combination of drugs

  This study is testing a new combination of drugs to see if it can help people with advanced nasopharyngeal cancer live longer without their cancer getting worse.

  Recruiting Phase 1 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06886347

• Using RMTT regimen as first-line therapy for primary central nervous system lymphoma

  This study is testing if a new combination treatment called RMTT can help people with primary central nervous system lymphoma who haven't had treatment before.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06832267

• Sacituzumab govitecan for HER2‑negative metastatic breast cancer in China

  This will test how well sacituzumab govitecan works and how safe it is for adults in China with HER2‑negative metastatic breast cancer.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06784921

• QL1706 combined with SOX for treating advanced gastric cancers

  This study is testing if a new treatment combining QL1706 and SOX can help people with advanced stomach cancer before surgery and improve their chances of recovery.

  Recruiting Phase 1/2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06766305

• Hepatic arterial infusion chemotherapy and immunotherapy for liver cancer

  This study is testing a new way to treat liver cancer by combining chemotherapy and immunotherapy directly into the liver to see if it works better than standard treatments.

  Recruiting Phase 1/2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang and 1 other locations · NCT06741020

• Study of how tranexamic acid works in ovarian cancer patients

  This study is testing how well tranexamic acid works in reducing blood loss during surgery for women with advanced ovarian cancer by comparing two different ways of giving the medication.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06728670

• Managing blood pressure during surgery to improve cognitive function in cancer patients

  This study is testing if keeping blood pressure at a higher level during surgery can help cancer patients think better and avoid confusion after their operation.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06711432

• Treatment for elderly patients with newly diagnosed double-expressor lymphoma

  This study is testing a new combination of treatments for older patients with a specific type of lymphoma to see if it helps them feel better and stay in remission.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06674096

• Cadonilimab combination treatment for advanced HER2-positive gastric cancer

  This study is testing a new combination treatment with cadonilimab for people with advanced HER2-positive gastric cancer to see how well it works and how safe it is.

  Recruiting Phase 1/2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06650332

• A model for screening and diagnosing abdominal tumors using CT scans

  This study is testing a new way to use CT scans to help find and diagnose abdominal tumors in patients who have them and those who don’t.

  Recruiting at 2 sites Zhejiang Cancer Hospital · Hangzhou, Zhejiang and 1 other locations · NCT06614179

• Evaluating IBI363 with chemotherapy for advanced gastric cancer

  This study is testing a new treatment combining IBI363 with chemotherapy for people with advanced stomach cancer to see if it helps them better than current options.

  Recruiting Phase 1 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06610799

• Using ctDNA to guide chemotherapy for elderly colon cancer patients after surgery

  This study tests if using a blood test to check for cancer DNA can help doctors decide the best chemotherapy for older patients with high-risk colon cancer after surgery.

  Recruiting Phase 3 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06609551

• Combination therapy of Disitamab Vedotin and Trastuzumab for HER2 positive gastric cancer

  This study is testing a new combination of two drugs, Disitamab Vedotin and Trastuzumab, to see if it can help people with advanced HER2 positive gastric cancer who haven't responded to other treatments.

  Recruiting Phase 1/2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06572319

• Combining adebrelimab with chemotherapy and SBRT for treating early-stage small cell lung cancer

  This study is testing if adding the immunotherapy drug adebrelimab to chemotherapy and radiation can help people with early-stage small cell lung cancer before they have surgery.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06562920

• Combination of Tislelizumab and Nab-Paclitaxel for Advanced Triple-Negative Breast Cancer with Bone Metastasis

  This study is testing if a new combination of Tislelizumab and Nab-Paclitaxel can effectively treat patients with advanced triple-negative breast cancer that has spread to their bones.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06538896

• Neoadjuvant treatment for esophageal squamous cell carcinoma

  This study is testing two different treatment plans for patients with operable esophageal squamous cell carcinoma to see which one works better and is safer before surgery.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06509568

• Combining Adebrelimab, Apatinib Mesylate, and Chemotherapy for Treating Limited-stage Small Cell Lung Cancer

  This study is testing a new combination of a drug called adebrelimab, another drug called apatinib mesylate, and chemotherapy to see if it helps people with newly diagnosed limited-stage small cell lung cancer.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06483282

• Screening for gastrointestinal tumors in patients

  This study is trying to see if a series of tests and questionnaires can help identify people at high risk for gastrointestinal tumors so they can get the right screenings and care.

  Recruiting at 2 sites Zhejiang Cancer Hospital · Jinhua, Zhejiang and 1 other locations · NCT06478030

• Investigating proteins related to postoperative delirium in diabetes patients

  This study is trying to see if certain proteins in the blood are linked to confusion after surgery in people with diabetes.

  Recruiting Zhejiang Cancer Hospital · Duyun, Guizhou and 1 other locations · NCT06426953

• Comparing neoadjuvant chemoimmunotherapy with immuno-consolidation for stage III lung cancer

  This study is testing whether a new combination of immunotherapy and chemotherapy before surgery works better than a different approach that uses immunotherapy after surgery for people with stage III lung cancer.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06424899

• Using sintilimab after chemoradiotherapy for elderly patients with esophageal cancer

  This study is testing if adding a new treatment called sintilimab after chemotherapy and radiation can help older patients with esophageal cancer live longer and healthier.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06413342

• Short-course radiation then tislelizumab plus anlotinib before and after surgery for stage II–IIIA lung cancer

  This study will try short-course radiotherapy followed by the immune drug tislelizumab and the targeted drug anlotinib given before and after surgery for people with stage II–IIIA non-small cell lung cancer.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06379087

• Combining SBRT with immunotherapy and chemotherapy for advanced head and neck cancer

  This study is testing if combining a new immune therapy with radiation and chemotherapy can help people with advanced head and neck cancer do better before surgery.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06306846

• Evaluating cardunolizumab for recurrent or metastatic vulvar and vaginal cancer

  This study is testing a new drug called cardunolizumab to see if it can help people with advanced vulvar and vaginal cancer that can't be treated with surgery.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06292689

• Adjuvant radiotherapy for high-risk esophageal cancer patients

  This study is testing if adding radiation therapy after surgery can help high-risk patients with esophageal cancer live longer and have better outcomes.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06272214

• Using Shengmai San to Prevent Heart Issues from Breast Cancer Treatment

  This study is testing whether a traditional Chinese medicine called Shengmai San can help prevent heart problems in people with HER2 positive breast cancer who are receiving certain chemotherapy treatments.

  Recruiting Phase 3 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06214195

• Using sintilimab after surgery for esophageal cancer

  This study tests if a medication called sintilimab can help prevent cancer from coming back in people who have had surgery for esophageal cancer.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06190639

• New methods for screening and diagnosing gastric cancer using tongue imaging

  This study is testing a new way to spot gastric cancer by looking at tongue images and other samples from both cancer patients and healthy people to see how they might be connected.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06078930

• New treatment approach for newly diagnosed mantle cell lymphoma

  This study is testing a new treatment plan for people with newly diagnosed mantle cell lymphoma to see if it can help them achieve better remission rates and improve their overall health.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT05992597

• Combining Lenvatinib, Tislelizumab, and TACE for Liver Cancer Treatment

  This study is testing a new combination treatment for liver cancer to see if it can help patients at high risk of their cancer coming back after surgery.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT05920863

• Combining inetetamab, pyrotinib, and vinorelbine for treating advanced HER2-positive breast cancer

  This study is testing a new combination of three drugs to see if they can help people with advanced HER2-positive breast cancer feel better and live longer.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT05856383

• Combining SBRT, chemotherapy, and tislelizumab for metastatic nasopharyngeal carcinoma

  This study is testing if combining a type of targeted radiation therapy, chemotherapy, and an immune booster can help people with advanced nasopharyngeal cancer feel better and live longer.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT05652192

• Neoadjuvant therapy for high-risk intrahepatic cholangiocarcinoma patients

  This study is testing a new combination treatment for patients with high-risk intrahepatic cholangiocarcinoma to see if it can improve their chances of successful surgery and survival.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang and 1 other locations · NCT05557578

• Combining radiotherapy with endostatin and capecitabine for nasopharyngeal carcinoma

  This study is testing if combining radiotherapy with two medications, endostatin and capecitabine, can help people with nasopharyngeal cancer who didn't respond to initial chemotherapy.

  Recruiting at 7 sites Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang and 6 other locations · NCT05514275

• Neoadjuvant therapy with immunotherapy for esophageal cancer

  This study is testing a new treatment combining radiation, chemotherapy, and an immunotherapy drug to see if it helps people with esophageal cancer before surgery.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hanzhou, Zhejiang and 2 other locations · NCT05507411

• Examining the effects of brachytherapy on gynecological cancers

  This study looks at how well brachytherapy works for women aged 18 to 80 with different types of gynecological cancers.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT05242861

• UGT1A1-guided irinotecan therapy for advanced rectal cancer

  This study is testing if adjusting the dose of irinotecan based on a specific gene can help people with advanced rectal cancer do better with their treatment before surgery.

  Recruiting Phase 4 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT05148767

• Using immune scores and radiomics to improve staging in nasopharyngeal carcinoma

  This study is testing a new way to stage nasopharyngeal cancer by combining immune system scores with imaging data to see if it can give a better understanding of patient outcomes and treatment options.

  Recruiting at 5 sites Zhejiang Cancer Hospital · Wuhan, Hubei and 4 other locations · NCT05126160

• Prophylactic irradiation for advanced cervical cancer

  This study is testing if adding a specific type of radiation treatment to standard therapy can help women with advanced cervical cancer live longer without their disease coming back.

  Recruiting Phase 3 Zhejiang Cancer Hospital · Hangzhou, Zhejiang and 6 other locations · NCT04974346

Quick answers

How many clinical trials run by Zhejiang Cancer Hospital are recruiting right now?

67, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 30, Phase 1/2: 5, Phase 3: 4, Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →